相关实验视频

Updated: Sep 13, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

瘤病毒治疗在黑色素瘤中的进展:综合性审查

Ayushi Garg¹, Rohit Rao^2,3, Felicia Tejawinata²

¹Wayne State University School of Medicine, Detroit, MI 48201, USA.

|July 30, 2025

概括

瘤溶解病毒疗法为黑色素瘤提供了一个有前途的免疫疗法,特别是当检查点抑制剂失败时. 这种方法使用工程病毒来向癌细胞并增强对抗性瘤的免疫反应.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
病毒学病毒学

背景情况:

检查点抑制剂疗法已经改变了黑色素瘤的治疗方法,但耐药性仍然是一个重大的临床挑战.
对于抗检查点抑制剂的黑色素瘤患者,存在有限的治疗选择.
瘤病毒代表了一种新的免疫疗法策略,可以选择性地向并摧毁瘤细胞,从而可能启动抗癌免疫反应.

研究的目的:

为提供对瘤瘤病毒治疗的综合性审查.
追踪型病毒治疗从历史性野生病毒到现代转基因平台的演变.
讨论瘤病毒在黑色素瘤治疗中的临床应用和挑战.

主要方法:

关于型病毒治疗的历史和当前文献的综述.
对黑色素瘤患者的talimogene laherparepvec和vusolimogene oderparepvec的临床试验数据的分析.
检查瘤病毒设计的进展,包括瘤选择性和免疫逃避策略.

主要成果:

瘤病毒,特别是与检查点抑制剂相结合时,可以增强治疗耐药黑色素瘤的抗瘤免疫力.
转基因病毒表现出改善的瘤向性,免疫应答逃避性和瘤治疗疗效.
临床试验的talimogene laherparepvec和vusolimogene oderparepvec提供了关于它们在黑色素瘤中的安全性和有效性的见解.

结论:

瘤性病毒治疗是一种不断发展和有价值的黑色素瘤治疗方式,特别是在检查点抑制剂耐药的情况下.
持续的研究和开发对于克服与瘤微环境中的瘤病毒相关的挑战至关重要.
本综述旨在为临床医生提供知识,以有效地利用瘤性病毒疗法治疗黑色素瘤患者.

关键词:

疹简单病毒病毒.在 RP-1 中使用 RP-1.这是T-VEC.腺病毒的病毒.发生瘤性病毒病史.免疫疗法免疫疗法黑色素瘤是一种黑色素瘤.型病毒型病毒一致的拉赫尔帕雷普维克.疫苗病毒病毒病毒病毒病毒.这种药物是有毒的或有毒的或有毒的.

更多相关视频

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...